Castle | $1,000,000 | (Jun 27, 2025)
Handspring Health | $12,000,000 | (Jun 27, 2025)
DejaBlue | $8,000,000 | (Jun 27, 2025)
Certified by Founder
Lodge
HEPHAISTOS-Pharma
start up
France
- Orsay, Île-de-France
- 17/05/2024
- Seed
- $11,189,199
HEPHAISTOS-Pharma est une startup en biotechnologie développant des immunothérapies anti-tumorales permettant de révolutionner les traitements contre le cancer en décuplant l'efficacité des anticorps monoclonaux et en permettant le traitement de tumeurs incurables.
- Industry Biotechnology
- Website https://hephaistos-pharma.fr/
- LinkedIn https://www.linkedin.com/company/hephaistos-pharma/
Related People
Frederic CAROFFFounder
France -
Boulogne-Billancourt, Île-de-France
Biotechnology entrepreneur for 10 years, I am currently the CEO of HEPHAISTOS-Pharma, a biotech company developing new immunotherapies in oncology in order to revolutionize the effectiveness of cancer treatments.
Our ONCO-Boost technology allows us to stimulate patients' immunity to treat cold tumors such as Osteosarcoma, an orphan disease, but also to increase the effectiveness of therapeutic antibodies in combination.
Certify | $40,000,000 | (Jun 27, 2025)
Tacta Systems, Inc. | $7,000,000 | (Jun 27, 2025)
Antler Bio | $4,212,546 | (Jun 27, 2025)
Raphe mPhibr | $100,000,000 | (Jun 27, 2025)
DataBahn.ai | $17,000,000 | (Jun 27, 2025)
Klutch AI | $8,000,000 | (Jun 27, 2025)
Niural | $31,000,000 | (Jun 27, 2025)
Jarsy Inc | $5,000,000 | (Jun 27, 2025)
Spekter Games | $5,000,000 | (Jun 27, 2025)